OTLK Outlook Therapeutics, Inc.
Price Chart
Executive Summary
Outlook Therapeutics filed an 8-K disclosing a registered direct offering of 8,539,709 shares of common stock to GMS Ventures and Investments, priced under an existing effective shelf registration statement. The offering represents approximately 9.6% dilution relative to the $89M market cap, providing near-term cash but pressuring the stock via share count expansion.
Actionable Insight
Monitor for the prospectus supplement to confirm pricing and use of proceeds. The dilutive overhang from this direct placement is likely to pressure OTLK near-term, especially given the stock's poor historical performance and negative calibration signals. Watch for any pipeline catalyst updates that could offset dilution sentiment.
Key Facts
- Registered direct offering of 8,539,709 shares to GMS Ventures and Investments
- Securities purchase agreement dated May 28, 2026
- Offering made under effective S-3 shelf (File No. 333-278340)
- Shares represent ~9.6% of pre-offering shares outstanding based on $89M market cap
- Proceeds use not disclosed in the filing
Financial Impact
8,539,709 shares issued; at ~$10.42/share (implied from $89M market cap / ~8.54M shares), offering could raise ~$89M, but exact pricing and proceeds are not disclosed
Risk Factors
- Dilution of ~9.6% from new shares could depress EPS and stock price
- No disclosure of use of proceeds — if used for general corporate purposes without near-term catalyst, sentiment may worsen
- Historical performance shows negative drift on OTLK filings, amplifying bearish risk
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-068306 |
| Document: tm2615979d1_ex5-1.htm | 0001104659-26-068306 |
| Document: 0001104659-26-068306-index-headers.html | 0001104659-26-068306 |
| Document: 0001104659-26-068306-index.html | 0001104659-26-068306 |
| Document: 0001104659-26-068306.txt | 0001104659-26-068306 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 3, 2026
11d ago
|
Insider Cluster
| $0.7950 $0.7767 | ▼ −2.30% | ▲ +0.27% | $1.22 (+53.46%) |
|
Jun 2, 2026
13d ago
|
Insider Cluster
| $0.8140 $0.8100 | ▼ −0.49% | ▲ +0.23% | $1.22 (+49.88%) |
|
Jun 1, 2026
13d ago
|
DEFA14A
| $0.8140 $0.8098 | ▲ +0.52% | ▼ −0.18% | $1.22 (−49.88%) |
|
Jun 1, 2026
13d ago
|
8-K
| $0.8430 $0.8140 | ▼ −3.44% | ▼ −3.58% | $1.22 (+44.72%) |
|
May 29, 2026
16d ago
|
8-K
| $0.8430 $0.8136 | ▲ +3.49% | ▲ +3.64% | $1.22 (−44.72%) |
|
May 29, 2026
16d ago
|
424B5
| $0.7300 $0.8430 | ▼ −15.48% | ▼ −15.20% | $1.22 (−67.12%) |
|
May 28, 2026
17d ago
|
8-K
| $0.7300 $0.8430 | ▼ −15.48% | ▼ −15.20% | $1.22 (−67.12%) |
|
May 28, 2026
17d ago
|
Press Release
| $0.7300 $0.8430 | ▼ −15.48% | ▼ −15.20% | $1.22 (−67.12%) |
|
May 27, 2026
18d ago
|
Insider Cluster
| $0.5860 $0.7400 | ▲ +26.28% | ▲ +25.73% | $1.22 (+108.19%) |
|
May 26, 2026
19d ago
|
Press Release
| $0.4000 $0.5860 | ▲ +46.50% | ▲ +46.49% | $1.22 (+205.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access